4 completed. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
Follow olpasiran: new trials by email Literature Review of olpasiran trials Research Report on olpasiran
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess the Effect of Olpasiran on QT/QTc Intervals in Healthy Participants Placebo, Olpasiran, Moxifloxacin - Basic Science | Phase 1 | Completed | Amgen | 32 | 2024-09-12 | 2026-10-23 |
| A Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Olpasiran in Participants With Normal Renal Function and Participants With Various Degrees of Renal Impairment Olpasiran - Renal Impairment | Phase 1 | Completed | Amgen | 33 | 2022-09-13 | 2026-10-23 |
| A Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Olpasiran in Participants With Various Degrees of Hepatic Impairment Olpasiran - Hepatic Impairment | Phase 1 | Completed | Amgen | 25 | 2022-09-13 | 2026-10-28 |
| A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Olpasiran in Chinese Participants With Elevated Serum Lipoprotein(a) Olpasiran - Elevated Serum Lipoprotein(a) | Phase 1 | Completed | Amgen | 24 | 2021-07-28 | 2025-02-10 |
Amgen (4)
United States (2) · Hong Kong (1) · United Kingdom (1)